Clinical insights on the typical presentation of prostate cancer and how the disease is diagnosed. Alicia Morgans, MD, MPH: Prostate cancer is often diagnosed when men don’t have any symptoms at all.

Advanced imaging techniques are allowing clinicians to pinpoint exactly where prostate cancer has spread in the body, therefore lending the opportunity for more exact staging and targeted treatment ...

MONROE TOWNSHIP, N.J. & OXFORD, England--(BUSINESS WIRE)--Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals ...

BOSTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Halda Therapeutics today announced that new clinical data on HLD-0915, the company’s first-in-class oral RIPTAC™ therapeutic, will be presented at the plenary ...

Patient Deidentified National Cancer Database is available from the American College of Surgeons and is not owned by the authors of this work. The following represents disclosure information provided ...

Full abstracts will be released by ASCO on Thursday, May 22, 2025, at 5:00 PM ET. Details from the presentations will be available following the event on the Candel website at Candel Media. * Dr.

SAN DIEGO, May 10, 2018 /PRNewswire/ -- GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that it will present results from seven studies featuring its Decipher® ...

SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence-based prognostic and predictive cancer tests, will present three abstracts at the 2024 ASCO Annual Meeting ...

Most people with prostate cancer won’t die from it. But it still kills more American men than any type of cancer except lung cancer, because prostate cancer is more common. Prostate cancer needs ...

The MarketWatch News Department was not involved in the creation of this content. Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will ...

Therefore, examining patterns of racial and ethnic disparities in PCa can further elucidate subgroups of AANHPI patients who may benefit from improved access to screening and policies designed to ...